1. Home
  2. LGND vs DOCN Comparison

LGND vs DOCN Comparison

Compare LGND & DOCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • DOCN
  • Stock Information
  • Founded
  • LGND 1987
  • DOCN 2011
  • Country
  • LGND United States
  • DOCN United States
  • Employees
  • LGND 68
  • DOCN N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • DOCN Retail: Computer Software & Peripheral Equipment
  • Sector
  • LGND Health Care
  • DOCN Technology
  • Exchange
  • LGND Nasdaq
  • DOCN Nasdaq
  • Market Cap
  • LGND 3.2B
  • DOCN 3.0B
  • IPO Year
  • LGND 1992
  • DOCN 2021
  • Fundamental
  • Price
  • LGND $191.31
  • DOCN $40.66
  • Analyst Decision
  • LGND Strong Buy
  • DOCN Buy
  • Analyst Count
  • LGND 8
  • DOCN 13
  • Target Price
  • LGND $144.71
  • DOCN $43.08
  • AVG Volume (30 Days)
  • LGND 139.7K
  • DOCN 2.9M
  • Earning Date
  • LGND 08-05-2025
  • DOCN 11-05-2025
  • Dividend Yield
  • LGND N/A
  • DOCN N/A
  • EPS Growth
  • LGND N/A
  • DOCN 87.43
  • EPS
  • LGND N/A
  • DOCN 1.32
  • Revenue
  • LGND $181,488,000.00
  • DOCN $832,812,000.00
  • Revenue This Year
  • LGND $18.41
  • DOCN $16.34
  • Revenue Next Year
  • LGND $18.87
  • DOCN $14.63
  • P/E Ratio
  • LGND N/A
  • DOCN $30.91
  • Revenue Growth
  • LGND 53.40
  • DOCN 13.29
  • 52 Week Low
  • LGND $81.74
  • DOCN $25.45
  • 52 Week High
  • LGND $129.90
  • DOCN $47.02
  • Technical
  • Relative Strength Index (RSI)
  • LGND 66.71
  • DOCN 56.38
  • Support Level
  • LGND $182.87
  • DOCN $37.84
  • Resistance Level
  • LGND $194.44
  • DOCN $41.14
  • Average True Range (ATR)
  • LGND 5.79
  • DOCN 2.06
  • MACD
  • LGND -0.38
  • DOCN -0.35
  • Stochastic Oscillator
  • LGND 81.23
  • DOCN 42.93

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About DOCN DigitalOcean Holdings Inc.

DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups, and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. Geographically, the company generates maximum revenue from North America and also has a presence in Europe, Asia, and the Rest of the world.

Share on Social Networks: